All Stories

  1. AB031. Validation of claims approach to identify asthma and COPD overlap syndrome patients in the United States

    Article • Journal of Thoracic Disease, July 2016, AME Publishing Company

    Dr Ozgur Tunceli

  2. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012

    Article • BMJ Open Diabetes Research & Care, April 2016, BMJ

    Dr Ozgur Tunceli

  3. Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment

    Article • Journal of Managed Care & Specialty Pharmacy, March 2016, Academy of Managed Care Pharmacy

    Dr Ozgur Tunceli

  4. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population

    Article • Current Medical Research and Opinion, February 2016, Informa Healthcare

    Dr Ozgur Tunceli

  5. Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment

    Article • Journal of Managed Care & Specialty Pharmacy, January 2016, Academy of Managed Care Pharmacy

    Dr Ozgur Tunceli

  6. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone

    Article • Value in Health, September 2015, Elsevier

    Dr Ozgur Tunceli

  7. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2015, Dove Medical Press

    Dr Ozgur Tunceli

  8. Assessment of Outpatient and Inpatient Antibiotic Treatment Patterns and Health Care Costs of Patients with Complicated Urinary Tract Infections

    Article • Clinical Therapeutics, September 2015, Elsevier

    Dr Ozgur Tunceli

  9. Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2015, Dove Medical Press

    Dr Ozgur Tunceli

  10. Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database

    Article • BMC Health Services Research, June 2015, Springer Science + Business Media

    Dr Ozgur Tunceli

  11. Baseline characteristics of patients provided Cancer Care within a Novel Commercial Health Plan Cancer Care quality program

    Article • Value in Health, May 2015, Elsevier

    Dr Ozgur Tunceli

  12. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study

    Article • April 2015, Springer Science + Business Media

    Dr Ozgur Tunceli

  13. Seasonal influenza vaccination trends from 2007–2011 in privately insured children and adults in the United States

    Article • Vaccine, November 2014, Elsevier

    Dr Ozgur Tunceli

  14. Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone-Salmeterol Combination for Asthma Management: A United States Retrospective Database Analysis

    Article • The Journal of Allergy and Clinical Immunology In Practice, November 2014, Elsevier

    Dr Ozgur Tunceli

  15. Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III

    Article • Current Medical Research and Opinion, October 2014, Informa Healthcare

    Dr Ozgur Tunceli

  16. A US database study characterizing patients initiating a budesonide–formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2014, Taylor & Francis

    Dr Ozgur Tunceli

  17. FRI0184 A Snapshot of Contemporary Urate-Lowering Therapy (ULT) Care and Serum Uric Acid (SUA) Monitoring in A US Commercially-Insured Gout Population

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr Ozgur Tunceli

  18. Comparative Effectiveness of Rosuvastatin Versus Other Statins on Low-Density Lipoprotein Cholesterol (LDL-C) Reduction in Moderate-Risk Patients

    Article • Journal of Clinical Lipidology, May 2014, Elsevier

    Dr Ozgur Tunceli

  19. Cost Profile of Patients with Gastric Cancer Using United States Administrative Claims Data

    Article • Value in Health, May 2014, Elsevier

    Dr Ozgur Tunceli

  20. Maximum Difference Scaling: A Novel Technique For Determining Patient Preferences

    Article • Value in Health, May 2014, Elsevier

    Dr Ozgur Tunceli

  21. Resource Use Associated with Patients with Thyroid Cancer in a United States Insured Population

    Article • Value in Health, May 2014, Elsevier

    Dr Ozgur Tunceli

  22. Rates Of Acute Coronary Events And All Cause Mortality In Patients With Stable Coronary Artery Disease (Cad) After Myocardial Infarction And Additional Cardiovascular Risk Factors

    Article • Value in Health, May 2014, Elsevier

    Dr Ozgur Tunceli

  23. Long Term Health Care Costs For Patients With Stable Coronary Artery Disease (Cad) After Myocardial Infarction In The United States

    Article • Value in Health, May 2014, Elsevier

    Dr Ozgur Tunceli

  24. Comparative Effectiveness Of Rosuvastatin Versus Other Statins On Low-Density Lipoprotein Cholesterol (Ldl-C) Reduction In High Risk Patients

    Article • Value in Health, May 2014, Elsevier

    Dr Ozgur Tunceli

  25. Treatment Patterns, HealthCare Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data

    Article • Clinical Therapeutics, December 2013, Elsevier

    Dr Ozgur Tunceli

  26. Doubling of Health Care Costs Among Asthma Patients with COPD Diagnosis and Its Associated Co-Morbidities in a Claims Database in the United States

    Article • Value in Health, November 2013, Elsevier

    Dr Ozgur Tunceli

  27. Comparison of commercial insurance databases to census data for age, gender and geographic region in the united states

    Article • Value in Health, May 2013, Elsevier

    Dr Ozgur Tunceli

  28. Establishing a weighting methodology to compute the number of patients with disease using claims data and census population in the united states

    Article • Value in Health, May 2013, Elsevier

    Dr Ozgur Tunceli

  29. Comparative Effectiveness of Budesonide/Formoterol Combination (BFC) and Fluticasone/Salmeterol Combination (FSC) Among Asthma Patients

    Article • Journal of Allergy and Clinical Immunology, February 2013, Elsevier

    Dr Ozgur Tunceli

  30. Evaluating the Differences in Characteristics of Asthma Patients Initiating Budesonide/Formoterol Combination (BFC) and Fluticasone/Salmeterol Combination (FSC)

    Article • Journal of Allergy and Clinical Immunology, February 2013, Elsevier

    Dr Ozgur Tunceli

  31. Propensity score matched assessment of treatment patterns and cost of erythropoiesis stimulating agent treatment in patients with cancer receiving myelosuppressive chemotherapy

    Article • Journal of Oncology Pharmacy Practice, December 2012, SAGE Publications

    Dr Ozgur Tunceli

  32. PMH13 A Real-World Us Retrospective Database Analysis Evaluating Treatment Patterns, Health Care Resource Utilization and Costs in Patients with Bipolar Disorder Newly Treated with Immediate Release (IR) or Extended Release (XR) Quetiapine Fumarate

    Article • Value in Health, June 2012, Elsevier

    Dr Ozgur Tunceli

  33. History Of Asthma Maintenance Medication Use And Asthma Exacerbation Risk Factors Before Initiation Of Inhaled Corticosteroid/long-acting β-agonist (ICS/LABA) Combination Therapy For Asthma: Comparison Of Budesonide/formoterol (BFC) And Fluticasone/sal...

    Article • Journal of Allergy and Clinical Immunology, February 2012, Elsevier

    Dr Ozgur Tunceli

  34. PCV106 RE-HOSPITALIZATION RATES OF ACUTE CORONARY SYNDROME PATIENTS IN REAL WORLD CLINICAL PRACTICE: OBSERVATIONS FROM A NATIONAL ADMINISTRATIVE CLAIMS DATA

    Article • Value in Health, May 2011, Elsevier

    Dr Ozgur Tunceli

  35. 25 Epoetin Alfa and Darbepoetin Alfa Costs by Dominant Dosing Interval in Chronic Kidney Disease Not on Dialysis

    Article • American Journal of Kidney Diseases, April 2011, Elsevier

    Dr Ozgur Tunceli

  36. PCN109 COMPARISON OF HOSPITALIZATION BURDEN BETWEEN METASTATIC AND NON-METASTATIC MELANOMA PATIENTS IN A US POPULATION

    Article • Value in Health, November 2010, Elsevier

    Dr Ozgur Tunceli

  37. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods

    Article • Current Medical Research and Opinion, May 2010, Informa Healthcare

    Dr Ozgur Tunceli

  38. The Use of Migraine Preventive Medications Among Patients with and without Migraine Headaches

    Article • Cephalalgia, July 2009, SAGE Publications

    Dr Ozgur Tunceli

  39. Cancer Survivorship, Health Insurance, and Employment Transitions among Older Workers

    Article • INQUIRY The Journal of Health Care Organization Provision and Financing, February 2009, SAGE Publications

    Dr Ozgur Tunceli

  40. PCV82 CHANGE IN LIPID VALUES, TARGET LIPID VALUE ATTAINMENT, AND ANNUAL HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS INITIATING COMBINATION STATIN AND EXTENDED-RELEASE NIACIN THERAPY

    Article • Value in Health, November 2008, Elsevier

    Dr Ozgur Tunceli